SCM
Silverarc Capital Management Portfolio holdings
AUM
$489M
This Quarter Return
+19.76%
1 Year Return
+71.55%
3 Year Return
+1,109.63%
5 Year Return
–
10 Year Return
–
AUM
$489M
AUM Growth
+$489M
(+2.1%)
Cap. Flow
-$56.8M
Cap. Flow
% of AUM
-11.63%
Top 10 Holdings %
Top 10 Hldgs %
54.97%
Holding
83
New
12
Increased
18
Reduced
24
Closed
22
Top Buys
| 1 |
CG Oncology
CGON
|
$14.1M |
| 2 |
Scholar Rock
SRRK
|
$12.1M |
| 3 |
Neurocrine Biosciences
NBIX
|
$11.4M |
| 4 |
Vaxcyte
PCVX
|
$9.36M |
| 5 |
UroGen Pharma
URGN
|
$8.79M |
Top Sells
| 1 |
VRNA
Verona Pharma
VRNA
|
$17.7M |
| 2 |
Nuvalent
NUVL
|
$15.5M |
| 3 |
Disc Medicine
IRON
|
$11.7M |
| 4 |
Syndax Pharmaceuticals
SNDX
|
$8.49M |
| 5 |
Wave Life Sciences
WVE
|
$8.49M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Communication Services | 0% |
| 3 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Solid Biosciences
SLDB
$427M
| – | – |
-452,239
| Closed | -$1.67M |
|
77
Tarsus Pharmaceuticals
TARS
$2.47B
| – | – |
-81,331
| Closed | -$4.18M |
|
78
Travere Therapeutics
TVTX
$1.56B
| – | – |
-408,849
| Closed | -$7.33M |
|
79
Unicycive Therapeutics
UNCY
$74M
| – | – |
-2,413,489
| Closed | -$1.39M |
|
|
VXRT
80
DELISTED
Vaxart
VXRT
| – | – |
-683,825
| Closed | -$278K |
|
|
81
Wave Life Sciences
WVE
$1.53B
| – | – |
-1,050,374
| Closed | -$8.49M |
|
82
Xenon Pharmaceuticals
XENE
$2.98B
| – | – |
-10,121
| Closed | -$340K |
|
83
SPDR NYSE Technology ETF
XNTK
$1.25B
| – | – |
0
| – | – |
|